Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
J INTS BIO Gives Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, at ESMO Asia 2023
2023-12-05 15:16
Ubie's AI Symptom Checker Used by 2 Million Americans in First Year, Fueling Pharma Partnerships
2023-12-05 00:00
Pioneering health innovations at China Int'l Supply Chain Expo
2023-12-04 22:20
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia
2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis
2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS
2023-12-04 21:00
MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs
2023-12-04 15:01
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
2023-12-04 13:19
280Bio doses first patient in Phase I clinical trial of TEB-17231, an oral pan-RAS inhibitor in patients with advanced cancers harboring mutations in KRAS, HRAS, or NRAS
2023-12-01 21:00
So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business
2023-12-01 18:00
GC Biopharma establishes mRNA production facility in Hwasun, Korea
2023-12-01 16:31
Registrational Phase III CLARIFY trial in prostate cancer commences
2023-11-30 22:16
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging
2023-11-30 22:10
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
2023-11-30 21:59
CABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formula
2023-11-30 21:00
The Best Class 4 Laser Therapy Machine Takes Center Stage at The 55th Dusseldorf International Hospital and Medical Equipment Exhibition in 2023
2023-11-30 20:40
UroFiber SuperPulsed Thulium Fiber Laser System Officially Debuts at MEDICA 2023
2023-11-30 20:30
111, Inc. Announces Third Quarter 2023 Unaudited Financial Results
2023-11-30 14:00
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
2023-11-29 21:58
1
48
49
50
51
52
801